Healthcare
AZ
Financial summary
Comparable pricing
7% below marketComparable Healthcare businesses sell at a median of 2.9x SDE, based on 705 listings. This one asks 2.7x, about 7% below that median. At the comparable median it would price ~$2.6M.Methodology refines over time.Comparable Healthcare businesses sell around $2.6M vs this $2.5M ask.
Methodology refines over time.
SBA financeability
Businesses in ambulatory health care are commonly SBA-financed. The figures below are the industry-category norm from SBA 7(a)/504 lending, a gauge of how financeable a deal like this tends to be.
Ambulatory Health Care benchmarks
Typical SBA leverage
70%
Industry charge-off
0.9%
Common term
10 yr
Median loan
$215,000
Active lenders in this category: The Huntington National Bank, Live Oak Banking Company, Newtek Bank, National Association.
Based on 25,465 SBA loans · source: SBA 7(a)/504 FOIA, as of 2026Q1 · industry-category level.
Detailed information
priced below 1.5x revenue and strong SDE.
Linked page lives on the broker site, not on OpenAcquisitions.
Key points
Business description
Established behavioral health and substance abuse treatment provider offering a comprehensive continuum of care for adults in recovery. Services include residential treatment, outpatient programming, and ongoing recovery support services. The company has built a strong reputation for clinical quality, individualized treatment planning, and long-term recovery outcomes. The organization operates with an experienced leadership team, including licensed clinicians, medical personnel, and operational staff, allowing for a smooth ownership transition and scalable growth opportunities. Revenue is supported through a diversified mix of commercial insurance reimbursement and private-pay clients, alongside established referral relationships and digital marketing channels. The business is fully operational and positioned for continued expansion under new ownership. Ideal acquisition opportunity for strategic operators, behavioral health groups, or investors seeking an established platform within the growing addiction treatment sector. Revenue and adjusted EBITDA based on 2026 TTM through 4/30/2026. Previous cash flow for 2025 was $435K, and $1.1 million in 2024 Proof of funds is highly encouraged. Reason For Sale: Retirement Training & Support: Sellers are willing to stay on for transition Facilities Information: All facilities are leased.
See something off?
